Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07670195
PHASE2

BCAAs in Concussion 3.0

Sponsor: Akiva Cohen

View on ClinicalTrials.gov

Summary

This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.

Official title: HIT HEADS 3.0: Head Injury Treatment: A Randomized, Placebo-controlled, Double-blinded, Therapeutic Clinical Trial of Branched Chain Amino Acids (BCAAs) in the Treatment of Concussion

Key Details

Gender

All

Age Range

11 Years - 23 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2026-07

Completion Date

2027-12

Last Updated

2026-06-26

Healthy Volunteers

Yes

Interventions

DRUG

BCAA

The three BCAAs will be combined together into a powder formulation.

OTHER

Placebo

The placebo formulation will have similar taste, texture, consistency and appearance as the BCAA formulation.